Tengion, Inc.
OTC: TNGNQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David I. Scheer
- Employees
- 25
- Headquarters
- Winston-Salem, United States
- IPO year
- 2022
- Market cap
- $4.0K
- Website
- http://www.tengion.com
Loading TNGNQ…
Loading profile data…Frequently asked questions about TNGNQ
What does Tengion, Inc. (TNGNQ) do?
Tengion, Inc. was a biotechnology company focused on regenerative medicine, established in 2003 and headquartered in Winston-Salem, North Carolina. Its primary objective was the discovery, development, manufacturing, and commercialization of advanced cellular therapeutic products, often termed "neo-organs." These innovations, comprising living c...
Where does TNGNQ trade?
Tengion, Inc. (TNGNQ) trades on the Other OTC.
What sector is TNGNQ in?
Tengion, Inc. (TNGNQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Tengion, Inc.?
David I. Scheer is the chief executive officer of Tengion, Inc. (TNGNQ).
Where is Tengion, Inc. headquartered?
Tengion, Inc. is headquartered in United States.
Does TNGNQ pay a dividend?
Tengion, Inc. (TNGNQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TNGNQ go public?
Tengion, Inc. (TNGNQ) completed its initial public offering in 2022.